Treatments of hereditary angioedema

TW202633623APending Publication Date: 2026-08-16KALVISTA PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114150512
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-07-15
Filing Date
2020-06-15
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073291_001
    Figure TWG2TA001073291_001
  • Figure TWG2TA001073291_002
    Figure TWG2TA001073291_002
  • Figure TWG2TA001073291_003
    Figure TWG2TA001073291_003
Patent Text Reader

Abstract

The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. Regular (or continuous) treatments of HAE are also provided.
Need to check novelty before this filing date? Find Prior Art